Personal information

No personal information available

Activities

Employment (1)

Novartis (India): Hyderabad, Telangana, IN

2015-08-03 to 2018-04-19 | Business Analyst (MES)
Employment
Source: Self-asserted source
Chayanika Gundu

Education and qualifications (2)

National Institute of Pharmaceutical Education and Research: Hyderabad, Telangana, IN

2018-08-01 to present | PhD (Pharmacology and toxicology)
Education
Source: Self-asserted source
Chayanika Gundu

National Institute of Pharmaceutical Education and Research Hyderabad: Hyderabad, Telangana, IN

2013-06-01 to 2015-08-01 | MS (Pharmacology and Toxicology)
Qualification
Source: Self-asserted source
Chayanika Gundu

Works (10)

Probucol attenuates NF-κB/NLRP3 signalling and augments Nrf-2 mediated antioxidant defence in nerve injury induced neuropathic pain

International Immunopharmacology
2022-01 | Journal article
Part of ISSN: 1567-5769
Source: Self-asserted source
Chayanika Gundu

Rosmarinic acid and mitochondria

Mitochondrial Physiology and Vegetal Molecules
2021 | Book chapter
Source: Self-asserted source
Chayanika Gundu

Mitochondrial remodelling-a vicious cycle in diabetic complications.

Molecular biology reports
2021-05 | Journal article
Contributors: Sherkhane B; Chayanika G; Sood A; Khatri DK; Singh SB
Source: Self-asserted source
Chayanika Gundu via Europe PubMed Central

PARP overactivation in neurological disorders

Molecular Biology Reports
2021-03 | Journal article
Contributors: Vijay Kumar Arruri; Chayanika Gundu; Islauddin Khan; Dharmendra Kumar Khatri; Shashi Bala Singh
Source: check_circle
Crossref

Carvacrol abates NLRP3 inflammasome activation by augmenting Keap1/Nrf-2/p62 directed autophagy and mitochondrial quality control in neuropathic pain.

Nutritional neuroscience
2021-02 | Journal article
Contributors: Arruri VK; Gundu C; Kalvala AK; Sherkhane B; Khatri DK; Singh SB
Source: Self-asserted source
Chayanika Gundu via Europe PubMed Central

Chronic hyperglycemia impairs mitochondrial unfolded protein response and precipitates proteotoxicity in experimental diabetic neuropathy: focus on LonP1 mediated mitochondrial regulation.

Pharmacological reports : PR
2020-07 | Journal article
Contributors: Kalvala AK; Yerra VG; Sherkhane B; Gundu C; Arruri V; Kumar R; Kumar A
Source: Self-asserted source
Chayanika Gundu via Europe PubMed Central

Bardoxolone Methyl Ameliorates Hyperglycemia Induced Mitochondrial Dysfunction by Activating the keap1-Nrf2-ARE Pathway in Experimental Diabetic Neuropathy.

Molecular neurobiology
2020-06 | Journal article
Contributors: Kalvala AK; Kumar R; Sherkhane B; Gundu C; Arruri VK; Kumar A
Source: Self-asserted source
Chayanika Gundu via Europe PubMed Central

An Overview on ATP Dependent and Independent Proteases Including an Anterograde to Retrograde Control on Mitochondrial Function; Focus on Diabetes and Diabetic Complications.

Current pharmaceutical design
2019-01 | Journal article
Contributors: Kalvala AK; Khan I; Gundu C; Kumar A
Source: Self-asserted source
Chayanika Gundu via Europe PubMed Central

Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy.

BioFactors (Oxford, England)
2017-11 | Journal article
Contributors: Bachewal P; Gundu C; Yerra VG; Kalvala AK; Areti A; Kumar A
Source: Self-asserted source
Chayanika Gundu via Europe PubMed Central

Autophagy: The missing link in diabetic neuropathy?

Medical hypotheses
2015-11 | Journal article
Contributors: Yerra VG; Gundu C; Bachewal P; Kumar A
Source: Self-asserted source
Chayanika Gundu via Europe PubMed Central